Sanofi CEO succession finalized
Executive Summary
Sanofi-Aventis' Board of Directors formally appoints Gerard Le Fur to succeed Jean-Francois DeHecq as the firm's CEO, effective Jan. 1, during a Dec. 14 meeting; DeHecq will remain board chairman. Le Fur, who currently serves as senior exec VP-science and medical affairs, was nominated for the post in May (1"The Pink Sheet" June 5, 2006, p. 11)...
You may also be interested in...
Sanofi-Aventis’ CEO Pipeline: R&D Chief Le Fur Tapped To Succeed Dehecq
Incoming Sanofi-Aventis CEO Gerard Le Fur will bring considerable research and development experience to the helm of the French drug maker
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.